6. Bibliografía

6.    Bibliografía

Doisneau-Sixou, S.F., C.M. Sergio, J.S. Carroll, R. Hui, E.A. Musgrove and R.L. Sutherland, 2003. Estrogen and antiestrogen regulation of cellcycle progression in breast cancer cells. Endocrine-Related Cancer, 10: 179-186.
Foster, J.S, D.C. Henley, S. Ahamed and J. Wimalasena, 2001. Estrogens and cell-cycle regulation in breast cancer. Trends in Endocrinology and Metabolism, 12: 320-327.
Oster, S.K., C.S. Ho, E.L. Soucie and L.Z. Penn, 2002. The myc oncogene: Marvelous Y complex. Advances in Cancer Research, 84:81-154.
Liu, M.M., C. Albanese, C.M. Anderson, K. Hilty, P. Webb, R.M. Uht, R.H. Price, R.G. Pestelland P.J.Kushner, 2002. Oposing action of estrogen receptorsand on ciclin D1 gene expression. J. Biol. Chem., 277:24353-24360.
Dickinson, R.B. and G.M. Stancel, 2000. Estrogen receptor-mediated processes in normal and cancer cells. J. Natl. Cancer Inst. Monogr. 27: 135-145.
Katzenellenbogen, B.S. and J.A. Katzenellenbogen, 2000. Estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer. Breast Cancer Res., 2: 335-344.
Alkhalaf, M. and A.M. El-Mowafy, 2003. Overexpression of wild-type p53 gene renders MCF-7 breast cancer cells more sensitive to the antiproliferative effect of progesterone. J. Endocrinol., 179:55-62.
Pasqualini, J.R., J. Paris, R. Sitruk-Ware, G. Chetrite and J. Botella, 1998. Progestins and breast cancer. J. Steroid Biochem. Mol. Biol., 65: 225-235.
Sartorius, C.A., T. Shen and K.B. Horowitz, 2003. Progesterone receptors A and B differentiall y affect the growth of estrogen-dependent human tumor xenografts. Breast Cancer Res. Treat., 79: 287-299.
Hanahan, D. and R.A. Weinberg, 2000. The hallmark of cancer. Cell, 100: 57-70.